Related Experiment Video
Updated: Mar 29, 2026

Candidate Gene Testing in Clinical Cohort Studies with Multiplexed Genotyping and Mass Spectrometry
Published on: June 21, 2018
Clinician Perspectives on Using Pharmacogenomics in Clinical Practice
Kim M Unertl1, Habiba Jaffa2, Julie R Field3
1Department of Biomedical Informatics, Vanderbilt University School of Medicine, Nashville, TN.
Clinicians in a pharmacogenomics program need better support for using genetic information in patient care. They face challenges with knowledge, workflow, and managing genomic results long-term.
Area of Science:
- Genomic Medicine
- Clinical Pharmacy
- Healthcare Implementation Science
Background:
- Pharmacogenomics implementation programs are expanding.
- Understanding clinician perspectives is crucial for successful integration of pharmacogenomics into routine care.
Purpose of the Study:
- To describe the knowledge and attitudes of clinicians involved in a large-scale pharmacogenomics implementation initiative.
- To identify barriers and facilitators to the adoption of pharmacogenomics in clinical practice.
Main Methods:
- Semi-structured interviews were conducted with 15 physicians and nurse practitioners.
- Qualitative thematic analysis was used to identify key themes from the interviews.
Main Results:
- Clinicians expressed challenges in keeping pace with rapidly evolving evidence.
- Strong support was noted for clinical decision support tools to aid in genotype-tailored therapies.
- Concerns were raised regarding communication of results, long-term responsibility for actionable findings, and provider hand-offs.
Conclusions:
- Clinicians perceive knowledge gaps and workflow integration as significant hurdles to pharmacogenomics adoption.
- Longitudinal responsibility for managing genomic variants presents a key challenge for successful implementation.
More Related Videos
08:46Implementation of In Vitro Drug Resistance Assays: Maximizing the Potential for Uncovering Clinically Relevant Resistance Mechanisms
Published on: December 9, 2015
08:59Looking for Driver Pathways of Acquired Resistance to Targeted Therapy: Drug Resistant Subclone Generation and Sensitivity Restoring by Gene Knock-down
Published on: December 11, 2017
Related Concept Videos
Pharmacogenetics and Pharmacogenomics: Overview
Pharmacogenetics of Drug Metabolism: Overview
Pharmacogenomics: Identification of New Drug Targets
Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu
Principles of Pharmacogenetics: Types of Genetic Variants
Pharmacogenetics of Phase I Enzymes: Cytochrome P450 Isozymes